NCT03076359

Brief Summary

The overall goal of this project is to adapt and assess the impact of a traditional healer training program/intervention on the adherence, retention, and viral load of HIV infected patients newly initiated on anti-retroviral therapy in rural Mozambique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 10, 2015

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

March 6, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 10, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

September 29, 2020

Completed
Last Updated

September 29, 2020

Status Verified

September 1, 2020

Enrollment Period

4 years

First QC Date

March 6, 2017

Results QC Date

August 10, 2020

Last Update Submit

September 8, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Retention in Care

    We accessed the percentage of days where participants have medication. For example, if a participant picked up a 30 day supply of medication on August 1st but did not collect their next medication until October 1st, the patient would only be considered retained for 50% of the time.

    Retention in care over 12 months

Secondary Outcomes (1)

  • Viral Load

    12 months post-enrollment

Study Arms (2)

Standard of Care

ACTIVE COMPARATOR

Intervention: This group will receive only standard of care HIV treatment, including ART medications (First-line ART will consist of two nucleoside reverse-transcriptase inhibitors (NRTIs) plus a non-nucleoside reverse-transcriptase inhibitor (NNRTI)- TDF + 3TC (or FTC) + EFV as a fixed-dose combination to be taken twice a day for the rest of the patient's life), clinic-based counseling, and community searches if lost to follow up.

Drug: Standard of Care

Traditional Healer Support Program

EXPERIMENTAL

This group will receive standard of care as described above. In addition, the investigators will assess an intervention partnership with traditional healer including: community and clinic based support from a trained traditional healer. The intervention includes: (1) healer visits to the patient at home, healer support for couples counseling, healer provision of nutritional advice, and healer counsel about the importance of adherence. If anything is amiss, the healer will accompany the patient to the health facility for additional clinical services. In addition, the healer will accompany the patient on all regularly scheduled clinical visits.

Behavioral: Traditional Healer Support ProgramDrug: Standard of Care

Interventions

Traditional Healers will provide the "traditional healer support program" assistance, as previously described, to all newly diagnosed patients.

Also known as: Adherence Support Workers
Traditional Healer Support Program

First-line ART will consist of two nucleoside reverse-transcriptase inhibitors (NRTIs) plus a non-nucleoside reverse-transcriptase inhibitor (NNRTI)- TDF + 3TC (or FTC) + EFV as a fixed-dose combination to be taken twice a day for the rest of the patient's life), clinic-based counseling, and community searches if lost to follow up.

Also known as: First Line ART
Standard of CareTraditional Healer Support Program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients: Individuals 18 years of age or older, HIV-infected, and newly enrolled in ART and treatment services at Namacurra Sede.
  • Traditional Healers: Healers will be eligible to participate if the healer lives within 10 km of the Namacurra Sede, received previous training from FGH, is 18 years of age or older, speak Portuguese, and see at least one patient per month

You may not qualify if:

  • Patients: Individuals that are currently pregnant, HIV-uninfected, and/or not yet enrolled in HIV care. Individuals who cannot give consent due to mental limitations or intoxication.
  • Traditional Healers: Healers who believe they can effectively treat or cure HIV or other associated conditions will be excluded from the project.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Namacurra Sede Health Facility

Namacurra, Zambezia Province, Mozambique

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Limitations and Caveats

A pre-post intervention has inherent temporal biases. At the start of the intervention phase Mozambique shifted to a test-and-treat system; the patients in the post-intervention phase are likely substantively different from the pre-group.

Results Point of Contact

Title
Carolyn Audet
Organization
Vanderbilt University

Study Officials

  • Carolyn Audet, PhD

    Vanderbilt University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 6, 2017

First Posted

March 10, 2017

Study Start

June 10, 2015

Primary Completion

May 30, 2019

Study Completion

June 30, 2019

Last Updated

September 29, 2020

Results First Posted

September 29, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations